[
  {
    "ts": null,
    "headline": "Exelixis: Zanzalintinib MOA Overcomes Competing CRC Regorafenib Treatment",
    "summary": "Exelixis: Zanzalintinib MOA Overcomes Competing CRC Regorafenib Treatment",
    "url": "https://finnhub.io/api/news?id=be8be3559bf7e0f4eaf87b79a514cd65d1ba6ac4d6f6bab18978ffdc52aa7f3f",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750683489,
      "headline": "Exelixis: Zanzalintinib MOA Overcomes Competing CRC Regorafenib Treatment",
      "id": 135484200,
      "image": "",
      "related": "BMY",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=be8be3559bf7e0f4eaf87b79a514cd65d1ba6ac4d6f6bab18978ffdc52aa7f3f"
    }
  }
]